로딩 중…
지수 로딩 중…
Savara Inc.
SVRA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$5.47+1.69%
2026-06-18
Price Chart
Savara Inc.+164.30%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.12B |
| Revenue | $0.00 |
| Net Income | $-129M |
| Total Assets | $222M |
| Net Assets | $176M |
| Value | |
| P/B | 6.37x |
| FCF Yield | -9.54% |
| Profitability | |
| ROE | -73.55% |
| ROA | -58.42% |
| Financial Health | |
| Debt Ratio | 25.91% |
| Total Debt | $30M |
| FCF | $-107M |
| Cash | $39M |
| Current Ratio | 13.47x |
| Performance | |
| 1Y Return | 164.30% |
| 1M Return | 15.91% |
| From 52W High | -21.95% |
| 1Y MDD | -39.71% |
| Trading | |
| Volume | 3,574,329 shares |
| Trading Value | $20M |
| Per Share | |
| EPS | $-0.53 |
| BPS | $0.91 |